CellEasyToulouse


Cell-Easy is a CDMO specializing in cell therapies. We provide a comprehensive suite of services designed to support biotech and pharmaceutical companies in the development and commercialization of in

read more close

novative cell-based treatments. Our offerings include: • Process & Analytical Development • GMP Manufacturing • CMC & Regulatory Support At Cell-Easy, our expert scientific team applies a robust Quality by Design (QbD) approach to ensure seamless technology transfer and successful development across a variety of cell-based therapies, including oncology, autoimmunity, and regenerative medicine. Our experience spans multiple modalities, including T cells, NK cells, MSCs, macrophages,

, France
Copy invite link
About
Cell-Easy
Toulouse

LikeShareFollow

Follow Me
CellEasyToulouse
https://www.abc-worldwide.com/site/CellEasyToulouse/news/
FR 3156-4964-5586-7616
Participant
Cell-Easy Toulouse
Cell-Easy is a CDMO specializing in cell therapies. We provide a comprehensive suite of services designed to support biotech and pharmaceutical companies in the development and commercialization of innovative cell-based treatments. Our offerings include: • Process & Analytical Development • GMP Manufacturing • CMC & Regulatory Support At Cell-Easy, our expert scientific team applies a robust Quality by Design (QbD) approach to ensure seamless technology transfer and successful development across a variety of cell-based therapies, including oncology, autoimmunity, and regenerative medicine. Our experience spans multiple modalities, including T cells, NK cells, MSCs, macrophages, HSCs, and exosomes.
Cell-Easy is a CDMO specializing in cell therapies. We provide a comprehensive suite of services designed to support biotech and pharmaceutical companies in the development and commercialization of innovative cell-based treatments. Our offerings include: • Process & Analytical Development • GMP Manufacturing • CMC & Regulatory Support At Cell-Easy, our expert scientific team applies a robust Quality by Design (QbD) approach to ensure seamless technology transfer and successful development across a variety of cell-based therapies, including oncology, autoimmunity, and regenerative medicine. Our experience spans multiple modalities, including T cells, NK cells, MSCs, macrophages, HSCs, and exosomes.
 
FR 3156-4964-5586-7616
CellEasyToulouse
Participant 04/2026 valid 04/2027
Trusted Seller

Trusted Seller